Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 14;18:1175–1193. doi: 10.2147/NDT.S279342

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Chauhan et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Frequency of selected adverse effects on sexual functioning, based on pooled data from short-term randomized trials of vilazodone for major depressive disorder in adults. This graph displays the pooled sex-specific frequencies of treatment-emergent adverse effects (TEAEs) with vilazodone (n=197) and placebo (n=198) on sexual performance by spontaneous self-report.⁶¹ Each ring in the graph represents the frequency of specified treatment-emergent adverse effects (TEAEs), ranging from 0% (at the center) to 14% (at the outer edge). * Erectile dysfunction is reported for men only.